title: Reporting of subset analysis: where do we draw the line?
authors.forename: Sanjay
authors.initials: S
authors.lastname: Goel
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068258:Bevacizumab; D016190:Carboplatin / Q000008:administration & dosage; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003627:Data Interpretation, Statistical; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D015999:Multivariate Analysis; D017239:Paclitaxel / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D016190:Carboplatin; D017239:Paclitaxel